Differential Expression of Toll-like Receptors in Dendritic Cells of Patients with Dengue during Early and Late Acute Phases of the Disease

PLoS Neglected Tropical Diseases

Volumn 7, Issue 2, 2013, Pages

  Torres, Silvia ^a,b   Hernández, Juan Carlos ^a,c   Giraldo, Diana ^a   Arboleda, Margarita ^d   Rojas, Mauricio ^a   Smit, Jolanda M ^b   Urcuqui Inchima, Silvio ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSIDAD COOPERATIVA DE COLOMBIA   (Colombia)

^d Instituto Colombiano de Medicina Tropical   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; CD123 ANTIGEN; CD14 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DENGUE; DENGUE VIRUS; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLUENZA VIRUS A; MALE; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STIMULATION; VIRUS TITRATION;

EID: 84874767745     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002060     Document Type: Article

References (52)

1. WHO (2009) Dengue and Dengue Hemorrhagic Fever. World Health Organization.
2. Lindenbach BD, Rice CM, (2003) Molecular biology of flaviviruses. Adv Virus Res 59: 23-61.
3. WHO (1997) Dengue Hemorrhagic fever: Diagnosis, treatment, prevention and control. World Health Organization.
4. Halstead SB, Nimmannitya S, Cohen SN, (1970) Observations related to pathogenesis of dengue hemorrhagic fever IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol MEd 42: 311-328.
5. de Kruif MD, Setiati TE, Mairuhu AT, Koraka P, Aberson HA, et al. (2008) Differential gene expression changes in children with severe dengue virus infections. PLoS Negl Trop Dis 2: e215.
6. Chau TN, Quyen NT, Thuy TT, Tuan NM, Hoang DM, et al. (2008) Dengue in Vietnamese infants-results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity. J Infect Dis 198: 516-524.
7. Boonnak K, Dambach KM, Donofrio GC, Tassaneetrithep T, Marovich MA, (2011) Cell Type Specificity and Host Genetic Polymorphisms Influence Antibody-Dependent Enhancement of Dengue Virus Infection. J Virol 85: 1671-1683.
8. van der Schaar HM, Wilschut JC, Smit JM, (2009) Role of antibodies in controlling dengue virus infection. Immunobiology 214: 613-629.
9. Vaughn DW, (2000) Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity. J Infect Dis 181: 2-9.
10. Takeda K, Akira S, (2007) Toll-like receptors. Curr Protoc Immunol Chapter 14: Unit 14.12.
11. Zarember KA, Godowski PJ, (2002) Tissue Expression of Human Toll-Like Receptors and Differential Regulation of Toll-Like Receptor mRNAs in Leukocytes in Response to Microbes, Their Products, and Cytokines. J Immunol 168: 554-561.
12. Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A, (2001) Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 11: 3388-3393.
13. Tsai YT, Chang SY, Lee CN, Kao CL, (2009) Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cell Microbiol 11: 604-615.
14. Modhiran N, Kalayanarooj S, Ubol S, (2010) Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse. PLoS Negl Trop Dis 4: e924.
15. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, et al. (2002) Molecular and Structural Immunology: Quantitative Expression of Toll-Like Receptor 1-10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides. J Immunol 168: 4531-4537.
16. Nguyen M, Leuridan E, Zhang T, De Wit D, Willems F, et al. (2010) Acquisition of Adult-Like TLR4 and TLR9 Responses during the First Year of Life. PLoS ONE 5: e10407.
17. Hernandez JC, Arteaga J, Paul S, Kumar A, Latz E, et al. (2011) Up-Regulation of TLR2 and TLR4 in Dendritic Cells in Response to HIV Type 1 and Coinfection with Opportunistic Pathogens. AIDS Res Hum Retroviruses 10: 1099-1109.
18. Hernandez JC, Stevenson M, Latz E, Urcuqui-Inchima S, (2012) HIV Type 1 Infection Up-Regulates TLR2 and TLR4 Expression and Function in Vivo and in Vitro. AIDS Res Hum Retroviruses 10: 1313-28.
19. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
20. Kadowaki N, Ho S, Antonenko S, De Waal Malefyt R, Kastelein RA, et al. (2001) Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens. J Exp Med 194: 863-870.
21. Perrot I, Deauvieau F, Massacrier C, Hughes N, Garrone P, Durand I, et al. (2010) TLR3 and Rig-Like Receptor on Myeloid Dendritic Cells and Rig-Like Receptor on Human NK Cells Are Both Mandatory for Production of IFN-γ in Response to Double-Stranded RNA. J Immunol 185: 2080-2088.
22. Marovich M, Grouard-Vogel G, Louder M, Eller M, Sun W, et al. (2001) Human dendritic cells as targets of dengue virus infection. J Investig Dermatol Symp Proc 6: 219-224.
23. Cella M, Sallusto F, Lanzavecchia A, (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9: 10-16.
24. Chutinimitkul S, Payungporn S, Theamboonlers A, Poovorawan Y J, (2005) Dengue typing assay based on real-time PCR using SYBR Green I. Virol Methods 129: 8-15.
25. Singh KR, Paul SD, (1969) Isolation of dengue viruses in Aedes albopictus cell cultures. Bull World Health Organ 40: 982-983.
26. Srikiatkhachorn A, Rothman AL, Gibbons RV, Sittisombut N, Malasit P, et al. (2011) Dengue-How Best to Classify It. Clin Infect Dis 53: 563-7.
27. Alvarez M, Rodriguez-Roche R, Bernardo L, Morier L, Guzman MG, (2005) Improved Dengue Virus Plaque Formation on BHK21 and LLCMK2 Cells: Evaluation of Some factors. Dengue Bulletin 29: 49-57.
28. Gagnon SJ, Mori M, Kurane I, Green S, Vaughn DW, et al. (2002) Cytokine gene-expression and protein production in peripheral blood mononuclear cells of children with acute dengue virus infections. J Med Virol 67: 41-46.
29. Chang DM, Shaio MF, (1994) Production of interleukin-1 (IL-1) and IL-1 inhibitor by human monocytes exposed to dengue virus. J Infect Dis 170: 811-817.
30. Lee YR, Liu MT, Lei HY, Liu CC, Wu JM, et al. (2006) MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J Gen Virol 87: 3623-3630.
31. Azeredo EL, Neves-Souza PC, Alvarenga AR, Reis SR, Torrentes-Carvalho A, et al. (2010) Differential regulation of toll-like receptor-2, toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever. Immunology 130: 202-216.
32. Nasirudeen AM, Wong HH, Thien P, Xu S, Lam KP, et al. (2011) RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl Trop Dis 5: e926 doi:10.1371/journal.pntd.0000926.
33. Wang JP, Liu P, Latz E, Golenbock DT, Finberg RW, et al. (2006) Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. J Immunol 177: 7114-7121.
34. Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA, (2001) Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol 75: 3501-3508.
35. Palmer DR, Sun P, Celluzzi C, Bisbing J, Pang S, et al. (2005) Differential effects of dengue virus on infected and bystander dendritic cells. J Virol 79: 2432-2439.
36. Velilla PA, Montoya CJ, Hoyos A, Moreno ME, Chougnet C, Rugeles MT, (2008) Effect of intrauterine HIV-1 exposure on the frequency and function of uninfected newborns' dendritic cells. Clin Immunol 3: 243-50.
37. Rodriguez-Madoz JR, Belicha-Villanueva A, Bernal-Rubio D, Ashou J, Ayllon J, et al. (2010) Inhibition of the Type I Interferon Response in Human Dendritic Cells by Dengue Virus Infection Requires a Catalytically Active NS2B3 Complex. J Virol 84: 9760-74.
38. Muñoz-Jordán JL, Sánchez-Burgos GG, Lauret-Rolle M, García-Sastre A, (2003) Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 24: 14333-38.
39. Mazzon M, Jones M, Davidson A, Chain B, Jacobs M, (2009) Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J Infect Dis 200: 1261-70.
40. Pang T, Cardosa MJ, Guzman MG, (2007) Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol 85: 43-45.
41. Steinman RM, Cohn ZA, (1974) Identification of a novel cell type in peripheral lymphoid organs of mice II. Functional properties in vitro. J Exp Med 139: 380-397.
42. Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, et al. (2007) Differential antigen processing by dendritic cell subsets in vivo. Science 315: 107-111.
43. Sun P, Fernandez S, Marovich MA, Palmer DR, Celluzzi CM, et al. (2009) Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. Virology 383: 207-215.
44. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA, (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
45. Krieg AM, (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20: 709-760.
46. Marshall JD, Heeke DS, Gesner ML, Livingston B, Van Nest G, (2007) Negative regulation of TLR9-mediated IFN-α induction by a small-molecule, synthetic TLR7 ligand. J Leukocyte Biol 82: 1-12.
47. Yoshida H, Jono H, Kai H, Li JD, (2005) The Tumor Supressor Cylindromatosis (CYLD) Acts as a Negative Regulator for Toll-like Receptor 2 Signaling via Negative Cross-talk with TRAF6 and TRAF7. J Biol Chem 280: 41111-41121.
48. Sun P, Bauza K, Pal S, Liang Z, Wu SJ, (2011) Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement. Virol 421: 245-252.
49. Kanda T, Steele R, Ray R, Ray RB, (2007) Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human hepatocytes. J Virol 81: 12375-12381.
50. Suharti C, van Gorp EC, Dolmans WM, Setiati TE, Hack CE, et al. (2003) Cytokine patterns during dengue shock syndrome. Eur Cytokine Netw 14: 172-177.
51. Mangada MM, Rothman AL, (2005) Altered cytokine responses of dengue specific CD4+ T cells to heterologous serotypes. J immunol 175: 2676-2683.
52. Akira S, (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nature 2: 675-680.